home2023-05-10T10:55:26+02:00

biomarkers for more stability in life

our purpose:
precision
medicine

discovery_and_validation_of_microRNA_biomarkers

TAmiRNA is a biotech company specialized in the discovery and validation of microRNA biomarkers. Our mission is to provide validated diagnostic solutions to patients with serious aging-related illnesses. We aim to improve and prolong patient stability, health and quality of life with increasing age.

TAmiRNA - stability for live

our technology:
microRNA
signatures

mircoRNA_signatures

We are specialized in biomarker development using blood-circulating microRNAs – evolutionary conserved regulators of gene expression and cell/tissue function. We develop diagnostic algorithms (“signatures”) based on the logic combination of microRNA levels and clinical parameters.

TAmiRNA - stability for live

our focus:
age-associated
diseases

age_associated_diseases

TAmiRNA is actively involved in R&D projects in osteoporosis (OP), cardio-vascular disease (CVD), liver disease and aging. OP and CVD are multifactorial illnesses. Using microRNA signatures we aim to decode the contributing disease factors on a personalized level, and to use this knowledge for better diagnosis.

TAmiRNA - stability for live

biomarkers for more stability in life

our purpose:
precision
medicine

discovery_and_validation_of_microRNA_biomarkers

TamiRNA is a biotech company specialized in the discovery and validation of microRNA biomarkers. Our mission is to provide validated diagnostic solutions to patients with serious aging-related illnesses. We aim to improve and prolong patient stability, health and quality of life with increasing age.

our technology:
microRNA
signatures

mircoRNA_signatures

We are specialized in biomarker development using blood-circulating microRNAs – evolutionary conserved regulators of gene expression and cell/tissue function. We develop diagnostic algorithms (“signatures”) based on the logic combination of microRNA levels and clinical parameters.

our focus:
age-associated
diseases

TAmiRNA is actively involved in R&D projects in osteoporosis (OP), cardio-vascular disease (CVD), liver disease and aging. OP and CVD are multifactorial illnesses. Using microRNA signatures we aim to decode the contributing disease factors on a personalized level, and to use this knowledge for better diagnosis.

our products

TAmiRNA - stability for live
TAmiRNA - stability for live
TAmiRNA - stability for live

our products

TAmiRNA - stability for live
TAmiRNA - stability for live
TAmiRNA - stability for live

our services

microRNA services

services

Serum, plasma, urine, saliva, exosomes, cells, and tissues … We provide solutions for your biomarker discovery and validation needs in any biological matrix.

TAmiRNA - the power of microRNA biomarkers

Kit services

Send us your samples to obtain results for osteomiR®, thrombomiR® or toxomiR® biomarkers by taking advantage of our in-house services.

TAmiRNA - the power of microRNA biomarkers
Click_here_for_your_personalized_microRNA_service_offer

our services

microRNA services

services

Serum, plasma, urine, saliva, exosomes, cells, and tissues … We provide solutions for your biomarker discovery and validation needs.

TAmiRNA - the power of microRNA biomarkers

One-Stop-Shop

Obtain results for osteomiR, thrombomiR,and toxomiR biomarkers in your samples by taking advantage of our inhouseservices.

TAmiRNA - the power of microRNA biomarkers
TAmiRNA - stability for live

latest news

TAmiRNA meets Japanese Pharma to present microRNA Biomarker Discovery Solutions

By |November 22nd, 2023|Categories: biomarker, biomarkers, exosomes, extracellular vesicle, microRNA, microRNA services, microRNAs, NGS, PCR testing service, SPI|Tags: , , , , , , , , |

Matthias Hackl, CEO/CSO of TAmiRNA, visited Japan between November 11th and 18th to join Summit Pharmaceutical international to introduce TAmiRNA to 12 medium- and large-size pharmaceutical companies. Matthias presented [...]

TAmiRNA at MEDICA Düsseldorf

By |November 8th, 2023|Categories: biomarker, biomarkers, microRNAs, smallRNA, thrombomiR, treatment monitoring|Tags: , , , |

TAmiRNA Senior Scientist Teresa Lara Krammer will attend MEDICA Düsseldorf next week to speak about “thrombomiRs - circulating microRNAs as novel platelet activation markers?”. Reach out to Teresa directly to [...]

Comments Off on TAmiRNA at MEDICA Düsseldorf

TAmiRNA at Extracellular Vesicles Forum

By |October 9th, 2023|Categories: biomarker, biomarkers, extracellular vesicle, microRNAs, NGS, smallRNA|Tags: , , , , , , |

TAmiRNA Scientific Consultant Magdalena Mecking is attending the Extracellular Vesicles Forum on Oct 10th – 11th in Cambridge. Stop by one of her posters and learn more about how [...]

Comments Off on TAmiRNA at Extracellular Vesicles Forum

TAmiRNA meets Japanese Pharma to present microRNA Biomarker Discovery Solutions

By |November 22nd, 2023|Categories: biomarker, biomarkers, exosomes, extracellular vesicle, microRNA, microRNA services, microRNAs, NGS, PCR testing service, SPI|Tags: , , , , , , , , |

Matthias Hackl, CEO/CSO of TAmiRNA, visited Japan between November 11th and 18th to join Summit Pharmaceutical international to introduce TAmiRNA to 12 medium- and large-size pharmaceutical companies. Matthias presented information on microRNA [...]

TAmiRNA at MEDICA Düsseldorf

By |November 8th, 2023|Categories: biomarker, biomarkers, microRNAs, smallRNA, thrombomiR, treatment monitoring|Tags: , , , |

TAmiRNA Senior Scientist Teresa Lara Krammer will attend MEDICA Düsseldorf next week to speak about “thrombomiRs - circulating microRNAs as novel platelet activation markers?”. Reach out to Teresa directly to meet with her [...]

Comments Off on TAmiRNA at MEDICA Düsseldorf

TAmiRNA at Extracellular Vesicles Forum

By |October 9th, 2023|Categories: biomarker, biomarkers, extracellular vesicle, microRNAs, NGS, smallRNA|Tags: , , , , , , |

TAmiRNA Scientific Consultant Magdalena Mecking is attending the Extracellular Vesicles Forum on Oct 10th – 11th in Cambridge. Stop by one of her posters and learn more about how TAmiRNA’s service may [...]

Comments Off on TAmiRNA at Extracellular Vesicles Forum
Go to Top